|
|
Sawsan Youssef, Gila Maor, Gizi Wildbaum, Nir Grabie, Alumit Gour-Lavie, Nathan Karin
J Clin Invest. 2000;
106(3):361
doi:10.1172/JCI9109
Abstract |
Full text
| PDF
D
epending on the method of immunization, a single administration of CFA may result in the development of a local inflammatory process or chronic polyadjuvant-induced arthritis (AA). We administered naked DNA vaccines encoding MIP-1α, MCP-1, MIP-1β, and RANTES to Lewis rats and confirmed that each of these vaccines induced immunological memory to the corresponding gene product. Upon induction of disease, this memory effectively inhibited the development of the autoimmune condition. Self-specific Ab’s developed in DNA-vaccinated animals were neutralizing in vitro and could adoptively transfer the beneficial effect of each vaccine. Repeated administration of the constructs encoding MCP-1, MIP-1α, or RANTES inhibited the development and progression of AA, even when each vaccine was administered only after the onset of disease. This suggests a highly effective way by which the immune system could be re-educated to generate protective immunity against its own harmful activities.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines
Pier Adelchi Ruffini, Gunnveig Grødeland, Agnete B. Fredriksen, Bjarne Bogen |
Vaccine |
2010 |
.
|
Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect
Shuxia Song, Chunyan Liu, Junxia Wang, Yan Zhang, Hongyu You, Yue Wang, Fuying Liu, Shuhan Sun |
Vaccine |
2009 |
.
|
CCL2 DNA vaccine to treat renal disease
Guoping Zheng, Huiling Wu, Yuan Min Wang, Yiping Wang, David C.H. Harris, S.I. Alexander, Debbie Watson |
J BIOCHEM CELL BIOL |
2009 |
.
|
Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody
Pierre Portalès, Sylvie Fabre, Thierry Vincent, Caroline Desmetz, Brigitte Réant, Danièle Noël, Jacques Clot, Christian Jorgensen, Pierre Corbeau |
Immunology |
2009 |
.
|
Emerging applications of anticytokine vaccines
Laure Delavallée, Eric Assier, Luca Semerano, Natacha Bessis, Marie-Christophe Boissier |
Expert Rev Vaccine |
2008 |
.
|
The development of novel therapies for rheumatoid arthritis
Ling-dong Quan, Geoffrey M Thiele, Jun Tian, Dong Wang |
eotp |
2008 |
.
|
Effects of MIP-1α, MIP-3α, and MIP-3β on the Induction of HIV Gag-specific Immune Response with DNA Vaccines
Ruijiang Song, Shuqin Liu, Kam W Leong |
Mol Ther |
2007 |
.
|
Joerg Reimann, Reinhold Schirmbeck, Martin Schleef |
Encyclopedia of Molecular Cell Biology and Molecular Medicine |
2006 |
.
|
Regulation of interleukin-1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts
Salahuddin Ahmed, Angela Pakozdi, Alisa E. Koch |
Arth Rheumat |
2006 |
.
|
Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networksin vivo
M Amat, C F Benjamim, L M Williams, N Prats, E Terricabras, J Beleta, S L Kunkel, N Godessart |
British Journal of Pharmacology |
2006 |
.
|
A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats
Ester Roffê, Adriano L.S. Souza, Bráulia C. Caetano, Patrícia P. Machado, Lucíola S. Barcelos, Remo C. Russo, Helton C. Santiago, Danielle G. Souza, Vanessa Pinho, Herbert B. Tanowitz |
Microbes Infec |
2006 |
.
|
The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis
Marlon P. Quinones, Carlos A. Estrada, Yogeshwar Kalkonde, Sunil K. Ahuja, William A. Kuziel, Matthias Mack, Seema S. Ahuja |
J Mol Med-JMM |
2005 |
.
|
Chemokines and their receptors in rheumatoid arthritis: Future targets?
Alisa E. Koch |
Arth Rheumat |
2005 |
.
|
DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy
Huiling Wu, Yiping Wang, Yuet-Ching Tay, Guoping Zheng, Chun Zhang, Stephen I. Alexander, David C.H. Harris |
Kidney Int |
2005 |
.
|
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines
Shawn M. Sumida, Paul F. McKay, Diana M. Truitt, Michael G. Kishko, Janelle C. Arthur, Michael S. Seaman, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton, Norman L. Letvin, Dan H. Barouch |
Journal Clinical Investigation |
2004 |
.
|
Therapeutic vaccination to block receptor–ligand interactions
Gunther Spohn, Martin F Bachmann |
ebot |
2003 |
.
|
Targeting monocyte chemoattractant protein-1 signalling in disease
Janet Dawson, Wolfgang Miltz, Anis K Mir, Christoph Wiessner |
eott |
2003 |
.
|
Technological advances to increase immunogenicity of DNA vaccines
Pierre Lemieux |
Expert Rev Vaccine |
2002 |
.
|
Gene therapy in rheumatic diseases
Margriet J.B.M. Vervoordeldonk, Paul P. Tak |
Best Pract Res Clin Rheumatol |
2001 |
.
|
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
Bryce Chackerian, Douglas R. Lowy, John T. Schiller |
Journal Clinical Investigation |
2001 |
.
|
|
|
|